COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

WY Chi, YD Li, HC Huang, TEH Chan, SY Chow… - Journal of biomedical …, 2022‏ - Springer
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …

Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus …

B Heidecker, N Dagan, R Balicer… - European journal of …, 2022‏ - Wiley Online Library
Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors,
recombinant protein, and inactivated virus have been administered worldwide. Although …

Circulating spike protein detected in post–COVID-19 mRNA vaccine myocarditis

LM Yonker, Z Swank, YC Bartsch, MD Burns, A Kane… - Circulation, 2023‏ - ahajournals.org
Background: Cases of adolescents and young adults develo** myocarditis after
vaccination with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–targeted …

Maternal vaccination and risk of hospitalization for Covid-19 among infants

NB Halasa, SM Olson, MA Staat… - … England Journal of …, 2022‏ - Mass Medical Soc
Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …

Evaluation of mRNA-1273 vaccine in children 6 months to 5 years of age

EJ Anderson, CB Creech, V Berthaud… - … England Journal of …, 2022‏ - Mass Medical Soc
Background The safety, reactogenicity, immunogenicity, and efficacy of the mRNA-1273
coronavirus disease 2019 (Covid-19) vaccine in young children are unknown. Methods Part …

BNT162b2 protection against the omicron variant in children and adolescents

AM Price, SM Olson, MM Newhams… - … England Journal of …, 2022‏ - Mass Medical Soc
Background Spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
B. 1.1. 529 (omicron) variant, which led to increased US hospitalizations for coronavirus …

[HTML][HTML] Hospitalizations of children and adolescents with laboratory-confirmed COVID-19—COVID-NET, 14 states, July 2021–January 2022

KJ Marks - MMWR. Morbidity and mortality weekly report, 2022‏ - cdc.gov
Coinciding with increased circulation of the Omicron variant, COVID-19–associated
hospitalization rates among children and adolescents aged 0–17 years increased rapidly in …

[HTML][HTML] Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19–associated hospitalization in infants aged 6 Months …

NB Halasa - MMWR. Morbidity and mortality weekly report, 2022‏ - cdc.gov
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against
COVID-19–Associated Hospitalization in Infants Aged 6 Months — 17 States, July 2021–January …

[HTML][HTML] Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19–associated emergency department and urgent care …

NP Klein - MMWR. Morbidity and mortality weekly report, 2022‏ - cdc.gov
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing
COVID-19–Associated Emergency Department and Urgent Care Encounters and …

Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis

WY Au, PPH Cheung - Bmj, 2022‏ - bmj.com
Objective To evaluate the effectiveness of heterologous and homologous covid-19 vaccine
regimens with and without boosting in preventing covid-19 related infection, hospital …